Y. Ohe - Concepedia

Author

Y. Ohe

National Cancer Center Hospital East

Also Known As

Silvia Novello, Y Ohe, Y. Ohe, Yuichiro Ohe

Publications

586

Citations

H-Index

Concepts

All Affiliations

National Cancer Center Hospital East National Cancer Research Institute Tokyo National Hospital

About

Y. Ohe is an author at National Cancer Center Hospital East specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	257
2	Health Sciences	2	2	63
3	Pathology	2	2	96
4	Immunology	1	1	24
5	Pharmacology	1	1	122

Y. Ohe

Publications

462

Citations

H-Index

Page 1

	Year	Citations
Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion Y. Ohe, Yusuke Sasaki, Tetsu Shinkai, JNCI Journal of the National Cancer Institute OncologyMedicineCancer ManagementMetronomic TherapyCancer Cell Biology	1992	122
Protective Effect of Magnesium Preloading on Cisplatin-induced Nephrotoxicity: A Retrospective Study Teruhiko Yoshida, Seiji Niho, M. Toda, Japanese Journal of Clinical Oncology	2014	80
Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen Seiji Niho, Y Nishiwaki, Koichi Goto, Lung Cancer Neuron-specific EnolaseSerum Pro-gastrin-releasing PeptideMedicinePathologyBronchial Neoplasm	2000	72
Randomized phase III trial comparing weekly docetaxel (D)-cisplatin (P) combination with triweekly D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): An intergroup trial of JCOG0803/WJOG4307L. Takashige Abe, Akira Yokoyama, Koji Takeda, Journal of Clinical Oncology Tri-weekly DTherapeutic Drug MonitoringElderly PatientsMedicineCancer Management	2011	39
Construction of a Novel Bovine Papillomavirus Vector Without Detectable Transforming Activity Suitable for Gene Transfer Y. Ohe, Dongyan Zhao, Nagahiro Saijo, Human Gene Therapy	1995	37
Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207 Hiroko Tsukada, Akira Yokoyama, Kōichi Goto, Japanese Journal of Clinical Oncology	2014	27
Intensive Chemotherapy with Cisplatin, Doxorubicin, Cyclophosphamide, Etoposide and Granulocyte Colony-stimulating Factor for Advanced Thymona or Thymic Cancer: Preliminary Results Fumihiro Oshita, T. Kasai, T Kurata, Japanese Journal of Clinical Oncology Thymic CancerImmunologyPathologyMetronomic ChemotherapyImmunotherapy	1995	24
Low-dose Irinotecan as a Second-line Chemotherapy for Recurrent Small Cell Lung Cancer Masahiro Morise, Seiji Niho, S. Umemura, Japanese Journal of Clinical Oncology	2014	22
A Randomized Prospective Study of Imipenem-Cilastatin With or Without Amikacin as an Empirical Antibiotic Treatment for Febrile Neutropenic Patients Akira Kojima, Tetsu Shinkai, Yoshifumi Soejima, American Journal of Clinical Oncology	1994	20
Phase I Studies of Cisplatin and Docetaxel Administered by Three Consecutive Weekly Infusions for Advanced Non-small Cell Lung Cancer in Elderly and Non-elderly Patients Y. Ohe Japanese Journal of Clinical Oncology	2001	19

Page 1